Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Applied and Environmental Microbiology

• Publication date

  2008-10-03

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/AEM.01019-08PMID 18836005PMCID PMC2592943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interrupting Vibrio cholerae infection of human epithelial cells with engineered commensal bacterial signaling

  2008cited by this paper
• Fluxome analysis using GC-MS

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• Efficient production and secretion of bovine β-lactoglobulin by Lactobacillus casei

  2007cited by this paper
• Faculty Opinions recommendation of Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.

  2006cited by this paper
• Forced expression of PDX-1 induces insulin production in intestinal epithelia.

  2006influential reference
• Effects of Age and Sex on Postprandial Glucose Metabolism

  2006cited by this paper
• Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1

  2006cited by this paper
• Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.

  2005influential reference
• Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1.

  2005cited by this paper
• Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus

  2005cited by this paper
• Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin‐2 in response to xylan

  2005cited by this paper
• Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells

  2003cited by this paper
• Genetically modified probiotics in foods.

  2003cited by this paper
• PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells.

  2002cited by this paper
• Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

  1999cited by this paper
• Glucagon-Like Peptide-1-(7-36)Amide Is Transformed to Glucagon-Like Peptide-1-(9-36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine1.

  1999cited by this paper

• The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota

  2025cites this paper
• Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment

  2025cites this paper
• Metabolic engineering of Lactobacilli spp. for disease treatment

  2025cites this paper
• Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities.

  2025cites this paper
• (Re-)Viewing Role of Intracellular Glucose Beyond Extracellular Regulation of Glucose-Stimulated Insulin Secretion by Pancreatic Cells

  2024cites this paper
• Peptide GLP-1 receptor agonists: From injection to oral delivery strategies.

  2024cites this paper
• Genetically Engineered Microorganisms and Their Impact on Human Health

  2024cites this paper
• Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness

  2023cites this paper
• Gut microbiome: New perspectives for type 2 diabetes prevention and treatment

  2023cites this paper
• Engineered bacteria as drug delivery vehicles: Principles and prospects

  2022cites this paper
• Harnessing gut cells for functional insulin production: Strategies and challenges

  2022cites this paper
• Probiotic Mechanisms Affecting Glucose Homeostasis: A Scoping Review

  2022cites this paper
• Role of the gut microbiota in type 2 diabetes and related diseases.

  2021cites this paper
• Regulation of Intestinal Barrier Function by Microbial Metabolites

  2021cites this paper
• Genetically engineered microbes for sustainable therapies

  2020cites this paper
• Deployment of Engineered Microbes: Contributions to the Bioeconomy and Considerations for Biosecurity

  2020cites this paper
• Engineering the gut microbiota to treat chronic diseases

  2020cites this paper
• Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP‐1 Analog Exhibits Potential Antiobesity Effect in High‐Fat Diet‐Induced Obesity Mice

  2020cites this paper
• Living Therapeutics: The Next Frontier of Precision Medicine.

  2020cites this paper
• Homologous quorum sensing regulatory circuit (hQSRC): A dual-input genetic controller for modulating quorum sensing (QS)-mediated protein expression in E. coli.

  2020cites this paper
• [Applications of engineered intestinal bacteria in disease diagnosis and treatment].

  2019cites this paper
• Synthetic gutomics: Deciphering the microbial code for futuristic diagnosis and personalized medicine

  2019cites this paper
• Emerging Frontiers in Microbiome Engineering.

  2019cites this paper
• Recent advances in developing and applying biosensors for synthetic biology

  2019cites this paper
• Emerging trends and research foci in gastrointestinal microbiome

  2019cites this paper
• Synthetic Biology and the Gut Microbiome

  2018cites this paper
• Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

  2018cites this paper
• Glucose Metabolism by Escherichia coli Inhibits Vibrio cholerae Intestinal Colonization of Zebrafish

  2018cites this paper
• Systems-synthetic biology in understanding the complexities and simple devices in immunology.

  2018cites this paper
• The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases

  2018influential citation
• Engineering Diagnostic and Therapeutic Gut Bacteria

  2017cites this paper
• Insulin chains as efficient fusion tags for prokaryotic expression of short peptides.

  2017cites this paper
• Cross feeding of glucose metabolism byproducts of Escherichia coli human gut isolates and probiotic strains affect survival of Vibrio cholerae

  2017cites this paper
• Lifestyle alters GUT-bacteria function: Linking immune response and host.

  2017cites this paper
• An Engineered Survival-Selection Assay for Extracellular Protein Expression Uncovers Hypersecretory Phenotypes in Escherichia coli.

  2017cites this paper
• Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)

  2017cites this paper
• Synthetic biology strategies towards the development of new bioinspired technologies for medical applications

  2017cites this paper
• The Intricate Relationship between Diabetes, Diet and the Gut Microbiota

  2017cites this paper
• Spatiotemporal Characterization of Stochastic Bacterial Growth in Biofilm Environment

  2017cites this paper
• Spatial dynamics of synthetic microbial mutualists and their parasites

  2017cites this paper
• Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application

  2016influential citation
• Gut microbiota, obesity and diabetes

  2016cites this paper
• Engineering the gut for insulin replacement to treat diabetes

  2016influential citation
• Evaluating and optimizing oral formulations of live bacterial vaccines using a gastro-small intestine model.

  2016cites this paper
• The Human Intestinal Microbiome in Health and Disease.

  2016cites this paper
• Development of a synthetic receptor protein for sensing inflammatory mediators interferon‐γ and tumor necrosis factor‐α

  2016cites this paper
• Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications.

  2016cites this paper
• Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes

  2015influential citation
• Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates

  2015cites this paper
• Towards in vivo editing of the human microbiome

  2015cites this paper
• Programmable probiotics for detection of cancer in urine

  2015cites this paper
• Investigation of host-microbe interactions in the probiotic bacteria Escherichia coli Nissle 1917

  2014cites this paper
• Synthetic Microbes As Drug Delivery Systems

  2014cites this paper
• Synthetic Biology for Therapeutic Applications

  2014cites this paper
• A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria.

  2014cites this paper
• Recent progress in engineering human-associated microbiomes.

  2014cites this paper
• Modulation of Gut Microbiota in the Management of Metabolic Disorders: The Prospects and Challenges

  2014cites this paper
• Complexity and network dynamics in physiological adaptation: an integrated view.

  2014cites this paper
• Chapter 1 Recent Progress in Engineering Human-Associated Microbiomes

  2014cites this paper
• Synthetic Biology Approaches to Cell Therapy

  2014cites this paper
• Designing Synthetic Gene Circuits for Homeostatic Regulation and Sensory Adaptation

  2013cites this paper
• ROLE OF MICROBES IN FUNCTIONAL FOODS FOR THE TREATMENT OF DIABETES

  2013cites this paper
• Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectives

  2013cites this paper
• Synthetic biological networks

  2013cites this paper
• Biomedical synthetic biology: an overview for physicians.

  2013cites this paper
• Genetic Circuits in Salmonella typhimurium

  2012cites this paper
• A retrosynthetic biology approach to therapeutics: from conception to delivery.

  2012cites this paper
• Network-Scale Engineering: Systems Approaches to Synthetic Biology

  2012cites this paper
• Bringing next-generation therapeutics to the clinic through synthetic biology.

  2012cites this paper
• Engineered E. coli that detect and respond to gut inflammation through nitric oxide sensing.

  2012cites this paper
• Probiotics Applications in Autoimmune Diseases

  2012cites this paper
• Engineering and control of biological systems: A new way to tackle complex diseases

  2012cites this paper
• Title : Probiotics as the potential biotherapeutics in the management of Type 2 Diabetes – Prospects and Perspectives

  2012cites this paper
• Genetic Circuits in Salmonella typhimurium

  2012cites this paper
• Genetic Circuits in Salmonella typhimurium

  2012cites this paper
• Oral enzyme therapy for celiac sprue.

  2012cites this paper
• A new approach to an old problem: synthetic biology tools for human disease and metabolism.

  2011cites this paper
• Compositions et méthodes de traitement de troubles endocriniens, gastro-intestinaux ou auto-immuns

  2011cites this paper
• From DNA to Targeted Therapeutics: Bringing Synthetic Biology to the Clinic

  2011cites this paper
• Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments

  2011cites this paper
• Emerging biomedical applications of synthetic biology

  2011cites this paper
• Synthetic Biology Moving into the Clinic

  2011cites this paper
• Potentials and Limitations of Bile Acids and Probiotics in Diabetes Mellitus

  2011cites this paper
• Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

  2010cites this paper
• Autonomous induction of recombinant proteins by minimally rewiring native quorum sensing regulon of E. coli.

  2010cites this paper
• Biological nanofactories target and activate epithelial cell surfaces for modulating bacterial quorum sensing and interspecies signaling.

  2010cites this paper
• The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic

  2009cites this paper
• EXAMINATION OF STATIONARY-PHASE GENE EXPRESSION IN CONTEXT OF REAL-WORLD APPLICATIONS OF SYNTHETIC MICROBES

  year unknowncites this paper